BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Effective Immediately: Immersion CEO Resigns, Interim Leader Named

  Carl Schlachte, currently Chairman of the Board, has been unanimously elected by the Board as Interim CEO.

  November 30, 2017

   · 

  4 min read
• BioMidwest

  Rotation Medical Bioinductive Implant Promotes Consistent Rotator Cuff Healing, Mitigates Tear Progression

  The Rotation Medical Bioinductive Implant is part of the company’s novel rotator cuff system for rotator cuff repair and a new alternative to traditional surgical repair.

  November 30, 2017

   · 

  4 min read
• Biotech Beach

  Agendia: New Data at the San Antonio Breast Cancer Symposium Demonstrate the Value of MammaPrint and BluePrint Across Breast Cancer Patient Populations

  A total of eleven posters and discussions are being presented at SABCS, which will take place at the Henry B. Gonzales Convention Center in San Antonio, Texas from December 5-9, 2017.

  November 30, 2017

   · 

  5 min read
• Business

  Pilot Chemical Names Pamela Butcher as CEO and President

  Pilot Chemical Company announced that Pamela Butcher has been named CEO and president, effective immediately.

  November 30, 2017

   · 

  2 min read
• Biotech Bay

  OptraSCAN On-Demand Digital Pathology Announces Next Generation System

  OptraSCAN today announced its next generation system at the Digital Pathology Congress meeting in London.

  November 30, 2017

   · 

  2 min read
• Business

  Targovax ASA: New Member of the Board of Directors – Nov. 30, 2017

  The previous chairman of the board, Jónas Einarsson, replaces Lars Lund-Roland as an ordinary member of the board of directors.

  November 30, 2017

   · 

  2 min read
• Drug Development

  Celldex Therapeutics Initiates Phase I Study of New Product Candidate CDX-1140 in Solid Tumors

  CDX-1140 is a fully human antibody targeted to CD40, a key activator of immune response that is found on dendritic cells, macrophages and B cells and is also expressed on many cancer cells.

  November 30, 2017

   · 

  5 min read
• BioCapital

  The Alliance for Regenerative Medicine Announces 2018 Cell & Gene Therapies State of the Industry Briefing

  The Alliance for Regenerative Medicine announced its 2018 Cell & Gene Therapies State of the Industry briefing will take place January 8, 2018 in San Francisco, held in conjunction with Biotech Showcase™ 2018.

  November 30, 2017

   · 

  3 min read
• Drug Development

  BeyondSpring Initiates Global Phase II/III Trial With Plinabulin in China for the Prevention of Chemotherapy-Induced Neutropenia to Demonstrate Superiority

  The initiation took place on Nov. 29, 2017, at the Harbin Medical University Cancer Hospital in Harbin, China, led by Co-Principal Investigator Dr. Qingyuan Zhang.

  November 30, 2017

   · 

  5 min read
• Drug Development

  RespireRx Pharmaceuticals Announces Publication of Phase IIB PACE Study: Once per Night Treatment with Dronabinol Provides Statistically Significant Improvement in Clinical Measures of Obstructive Sleep Apnea

  The PACE paper is published in the journal SLEEP, the official publication of the Sleep Research Society, and the leading peer-reviewed journal in sleep and circadian science.

  November 30, 2017

   · 

  10 min read